Shares of CME Group Inc. (NASDAQ:CME) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $134.33.

CME has been the subject of several recent research reports. Jefferies Group LLC reissued a “buy” rating and issued a $128.00 price objective on shares of CME Group in a report on Monday, July 10th. Deutsche Bank AG reaffirmed a “buy” rating and set a $133.00 target price (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 target price on shares of CME Group in a report on Friday, July 14th. Citigroup Inc. started coverage on CME Group in a report on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price for the company. Finally, BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/cme-group-inc-cme-receives-134-33-average-price-target-from-analysts/1528333.html.

CME Group (CME) traded down 0.20% on Wednesday, reaching $126.84. 418,898 shares of the company were exchanged. The stock has a 50 day moving average of $123.67 and a 200 day moving average of $121.36. CME Group has a 12-month low of $98.95 and a 12-month high of $127.96. The firm has a market capitalization of $43.11 billion, a PE ratio of 25.89 and a beta of 0.73.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. During the same quarter last year, the firm posted $1.14 EPS. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. Equities analysts anticipate that CME Group will post $4.80 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 2.08%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $124.50, for a total transaction of $311,250.00. Following the completion of the transaction, the chief financial officer now owns 38,495 shares of the company’s stock, valued at $4,792,627.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Derek Sammann sold 2,100 shares of the business’s stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $117.86, for a total value of $247,506.00. Following the transaction, the insider now directly owns 31,026 shares of the company’s stock, valued at approximately $3,656,724.36. The disclosure for this sale can be found here. Insiders have sold 80,820 shares of company stock valued at $10,033,166 in the last three months. 0.57% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. raised its position in shares of CME Group by 2,172.6% in the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock valued at $3,239,152,000 after buying an additional 26,065,883 shares during the last quarter. Janus Henderson Group PLC increased its stake in CME Group by 13,530.7% in the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after buying an additional 6,104,897 shares during the last quarter. Edgewood Management LLC increased its stake in CME Group by 26.4% in the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock worth $858,728,000 after buying an additional 1,511,753 shares during the last quarter. APG Asset Management N.V. increased its stake in CME Group by 335.2% in the first quarter. APG Asset Management N.V. now owns 1,899,723 shares of the financial services provider’s stock worth $225,687,000 after buying an additional 1,463,198 shares during the last quarter. Finally, Fiera Capital Corp increased its stake in CME Group by 243.9% in the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock worth $241,327,000 after buying an additional 1,366,557 shares during the last quarter. 82.66% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.